Julian Champagnie

Ask VT AI
View News Summary
  • Arizona's pass defense shines, but their pass rush struggles as they seek to end a four-game road losing streak.
  • Analysts warn of risky small-cap names and elevated valuations, but highlight stronger performers like Energy Recovery and Bank OZK.
  • Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Arizona's pass defense shines, but their pass rush struggles as they seek to end a four-game road losing streak.
  • Analysts warn of risky small-cap names and elevated valuations, but highlight stronger performers like Energy Recovery and Bank OZK.
  • Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Julian Champagnie